Works matching IS 02770008 AND DT 2024 AND VI 44 AND IP 5

Results: 8

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis.
Published in:
Pharmacotherapy, 2024, v. 44, n. 5, p. 394, doi. 10.1002/phar.2925
By:
- White, C. Michael;
- Caroti, Kimberly Snow;
- Bessada, Youssef;
- Hernandez, Adrian V.;
- Baker, William L.;
- Dobesh, Paul P.;
- van Haalen, Heleen;
- Rhodes, Kirsty;
- Coleman, Craig I.
Publication type:
Article
Expert consensus recommendations for innovative antiretroviral drugs.
Published in:
Pharmacotherapy, 2024, v. 44, n. 5, p. 352, doi. 10.1002/phar.2924
By:
- DeVane, C. Lindsay
Publication type:
Article
Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database.
Published in:
Pharmacotherapy, 2024, v. 44, n. 5, p. 383, doi. 10.1002/phar.2920
By:
- Sarker, Jyotirmoy;
- Carkovic, Emir;
- Ptaszek, Karolina;
- Lee, Todd A.
Publication type:
Article
Response to comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
Published in:
Pharmacotherapy, 2024, v. 44, n. 5, p. 411, doi. 10.1002/phar.2919
By:
- Price, Lily;
- Garrity, Lisa;
- Stiehl, Sarah
Publication type:
Article
Comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
Published in:
Pharmacotherapy, 2024, v. 44, n. 5, p. 409, doi. 10.1002/phar.2918
By:
- Zhang, Yongyi;
- Zhang, Qiushun;
- Zhang, Junchen
Publication type:
Article
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
Published in:
Pharmacotherapy, 2024, v. 44, n. 5, p. 360, doi. 10.1002/phar.2914
By:
- Cluck, David B.;
- Chastain, Daniel B.;
- Murray, Milena;
- Durham, Spencer H.;
- Chahine, Elias B.;
- Derrick, Caroline;
- Dumond, Julie B.;
- Hester, E. Kelly;
- Jeter, Sarah B.;
- Johnson, Melissa D.;
- Kilcrease, Christin;
- Kufel, Wesley D.;
- Kwong, Jeffrey;
- Ladak, Amber F.;
- Patel, Nimish;
- Pérez, Sarah E.;
- Poe, Jonell B.;
- Bolch, Charlotte;
- Thomas, Ian;
- Asiago‐Reddy, Elizabeth
Publication type:
Article
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary
Published in:
Pharmacotherapy, 2024, v. 44, n. 5, p. 354, doi. 10.1002/phar.2913
By:
- Cluck, David B.;
- Chastain, Daniel B.;
- Murray, Milena;
- Durham, Spencer H.;
- Chahine, Elias B.;
- Derrick, Caroline;
- Dumond, Julie B.;
- Hester, E. Kelly;
- Jeter, Sarah B.;
- Johnson, Melissa D.;
- Kilcrease, Christin;
- Kufel, Wesley D.;
- Kwong, Jeffrey;
- Ladak, Amber F.;
- Patel, Nimish;
- Pérez, Sarah E.;
- Poe, Jonell B.;
- Bolch, Charlotte;
- Thomas, Ian;
- Asiago‐Reddy, Elizabeth
Publication type:
Article
Issue Information.
Published in:
Pharmacotherapy, 2024, v. 44, n. 5, p. 349, doi. 10.1002/phar.2694
Publication type:
Article